622 related articles for article (PubMed ID: 9794372)
1. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
2. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
3. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
4. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
5. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
[TBL] [Abstract][Full Text] [Related]
8. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
9. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
10. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.
Kaye J; Hsu ML; Sauron ME; Jameson SC; Gascoigne NR; Hedrick SM
Nature; 1989 Oct; 341(6244):746-9. PubMed ID: 2571940
[TBL] [Abstract][Full Text] [Related]
11. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation.
Ishikawa S; Kowal C; Cole B; Thomson C; Diamond B
J Immunol; 1995 May; 154(10):5023-9. PubMed ID: 7730609
[TBL] [Abstract][Full Text] [Related]
12. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
[TBL] [Abstract][Full Text] [Related]
13. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
14. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
15. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection.
Dave VP; Allman D; Wiest DL; Kappes DJ
J Immunol; 1999 May; 162(10):5764-74. PubMed ID: 10229809
[TBL] [Abstract][Full Text] [Related]
16. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
17. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex.
Laufer TM; DeKoning J; Markowitz JS; Lo D; Glimcher LH
Nature; 1996 Sep; 383(6595):81-5. PubMed ID: 8779719
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
20. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]